MRP Capital Investments’s Bristol-Myers Squibb BMY Stock Holding History

MRP Capital Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.34K	Hold	58	–	–	﹤0.01%	207
2026 Q1	$3.52K	Hold	58	–	–	﹤0.01%	192
2025 Q4	$3.13K	Sell	58 -4,100	-99%	-$197K	﹤0.01%	185
2025 Q3	$192K	Hold	4,158	–	–	0.17%	91
2025 Q2	$192K	Sell	4,158 -5,950	-59%	-$292K	0.13%	87
2025 Q1	$616K	Buy	10,108 +750	+8%	+$43.7K	0.58%	57
2024 Q4	$529K	Buy	9,358 +9,300	+16,034%	+$520K	0.48%	64
2024 Q3	$3K	Buy	+58	New	+$2.72K	﹤0.01%	187
2023 Q3	–	Sell	-58	Closed	-$3.71K	–	105
2023 Q2	$3.71K	Sell	58 -201	-78%	-$13.5K	﹤0.01%	220
2023 Q1	$18K	Buy	259 +201	+347%	+$14.2K	0.02%	170
2022 Q4	$4.17K	Buy	+58	New	+$4.37K	﹤0.01%	196

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

MRP Capital Investments's BMY Position: Q2 2026 in Review

MRP Capital Investments held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 58 shares worth $3.34K. The position accounts for ﹤0.01% of the portfolio, ranked #207.

MRP Capital Investments first reported a position in BMY in Q4 2022 and has held it in 11 quarters since. The position peaked at $616K in Q1 2025. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

MRP Capital Investments held 58 shares of Bristol-Myers Squibb worth $3.34K as of Q2 2026.
MRP Capital Investments left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up ﹤0.01% of MRP Capital Investments's portfolio in Q2 2026, its #207 holding.
MRP Capital Investments first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 11 quarters since.
MRP Capital Investments's Bristol-Myers Squibb position peaked at $616K in Q1 2025.
2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on MRP Capital Investments's 13F filing for Q2 2026, filed 10 Aug 2026.